AHMED MAHIUDDIN (Sr. VP and CSO) sold 12.9% of their position (29.49K shares) of Y-MABS THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.16M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 5/20/2020ACC: 0001104659-20-064258
Officer· Sr. VP and CSO
Since Jan 2020
-29.49K
Net shares
Net seller
$1.16M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
29.49K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−19.49K
Price / share
$39.49
Trade value
$769.67K
% of position
8.5%
5/18/2020
229.49K→210K
Common Stock
Direct
Shares
−10K
Price / share
$39.24
Trade value
$392.40K
% of position
4.8%
5/19/2020
210K→200K
Total
Net shares
−29.49K
Net value
-$1.16M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/18/2020 | S · Sale | −19.49K | $39.49 | $769.67K | 8.5% | 229.49K | 210K |
| Common Stock Direct | 5/19/2020 | S · Sale | −10K | $39.24 | $392.40K | 4.8% | 210K | 200K |
| Total | −29.49K | -$1.16M | ||||||
Derivative Transactions0
No derivative transactions reported